Shopping Cart
Remove All
Your shopping cart is currently empty
Namitecan is an effective inhibitor of topoisomerase I. It has antitumor property.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,620 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,110 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,380 | 10-14 weeks | 10-14 weeks |
| Description | Namitecan is an effective inhibitor of topoisomerase I. It has antitumor property. |
| In vitro | Namitecan decreases a dose-dependent decrease in EGFR expression in the different cell lines[1]. Namitecan and cetuximab cooperate in inhibiting EGFR expression. ST1968 causes a comparable level of apoptosis in A431 and A431/TPT cells (IC50: 0.21 and 0.29 μM)[2]. |
| In vivo | Namitecan (10 mg/kg) combined with cetuximab (1 mg/mouse) demonstrates synergistic antitumor effects in SCC models, dependent on the EGFR gene copy number[1]. ST1968 (25 mg/kg) is associated with tolerable body weight loss and no fatal toxicity, achieving a 100% complete response rate in mice with the A431 tumor, and maintaining significant efficacy in topotecan-resistant tumors[2]. |
| Synonyms | ST-1968 |
| Molecular Weight | 434.44 |
| Formula | C23H22N4O5 |
| Cas No. | 372105-27-6 |
| Relative Density. | 1.51 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.